Skip to contents

  12. Morris, Randall E.

    Randall E. Morris, MD, FRCP : Stanford University School of Medicine and former Global Head of Transplantation Therapeutic Area (Discovery Research) and Global Head of Transplantation Translational Medicine, Novartis, AG, Basel, Switzerland : Stanford University School of Medicine and former Global Head of Transplantation Therapeutic Area (Discovery Research) and Global Head of Transplantation Translational Medicine, Novartis, AG, Basel, Switzerland

    Articles
    View online
    Schließen

    Access

    Close

    Bookmarks

    You can manage bookmarks using lists, please log in to your user account for this.

    Ovid Technologies (Wolters Kluwer Health), 2015

    Published in: Transplantation, 99 (2015) 8, Seite 1544-1546

  13. “Glivec” : Patents Act, 1970, Secs. 2(1)(j) and (ja) and 3(d) – Novartis AG, Natco Pharma Ltd. and M/S Cancer Patients Aid Association v. Union of India and Others : Patents Act, 1970, Secs. 2(1)(j) and (ja) and 3(d) – Novartis AG, Natco Pharma Ltd. and M/S Cancer Patients Aid Association v. Union of India and Others

    Articles
    View online
    Schließen

    Access

    Close

    Bookmarks

    You can manage bookmarks using lists, please log in to your user account for this.

    Springer Science and Business Media LLC, 2013

    Published in: IIC - International Review of Intellectual Property and Competition Law, 44 (2013) 7, Seite 843-844

  14. C-207/03 Novartis AG, University College London and Institute of Microbiology and Epidemiology v Comptroller-General of Patents, Designs and Trade Marks for the UK and C-252/03 Ministre de L'économie v Millennium Pharmaceuticals Inc

    Articles
    View online
    Schließen

    Access

    Close

    Bookmarks

    You can manage bookmarks using lists, please log in to your user account for this.

    SAGE Publications, 2005

    Published in: Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector, 2 (2005) 2, Seite 161-167

  15. LaBounty, Troy M.; Devereux, Richard B.; Lin, Fay Y.; Weinsaft, Jonathan W.; Min, James K.

    Impact of Coronary Computed Tomographic Angiography Findings on the Medical Treatment and Control of Coronary Artery Disease and Its Risk Factors††Conflicts of interest: Dr. Min has a research grant from GE Healthcare, Milwaukee, Wisconsin; is on the speaker's bureau for GE Healthcare; has a research grant from Vital Images, Minnetonka, Minnesota; and is a consultant for the Cordis Corporation, Miami Lakes, Florida. Dr. Devereux is a consultant for Merck & Company, Whitehouse Station, New Jersey; Novartis AG, Basel, Switzerland; Sanofi-Aventis, Paris, France; and Novo Nordisk A/S, Bagsværd, Denmark

    Articles
    View online
    Schließen

    Access

    Close

    Bookmarks

    You can manage bookmarks using lists, please log in to your user account for this.

    Elsevier BV, 2009

    Published in: The American Journal of Cardiology, 104 (2009) 7, Seite 873-877